Jubilant Pharmova Announces 48th AGM on Aug 26, 2026, Proposes ₹5 Dividend
Jubilant Pharmova Limited will hold its 48th AGM on August 26, 2026, via VC/OAVM. The company proposes a ₹5 per equity share dividend for FY 2025-26 and will adopt FY26 financial statements. Cut-off for voting is August 19, 2026, with remote e-voting from August 23-25, 2026.
The announcement pertains to a standard annual general meeting and dividend proposal, which are routine corporate events and do not represent a significant deviation or a major strategic shift for the company.
The announcement is a routine procedural notice regarding the AGM and dividend declaration, with no unexpected or significantly positive/negative financial information presented.
Jubilant Pharmova Limited has announced its 48th Annual General Meeting (AGM) will be held on Wednesday, August 26, 2026, at 11:00 a.m. IST through Video Conferencing/Other Audio-Visual Means (VC/OAVM). The company has also released its Annual Report for the Financial Year 2025-26.
The AGM agenda includes the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026. Additionally, the Board has recommended a Final Dividend of ₹5 per equity share for FY 2025-26, subject to approval by the members at the AGM. The company also plans to appoint directors, with Mr. Hari S. Bhartia and Mr. Arjun Shanker Bhartia retiring by rotation and offering themselves for re-appointment.
Members holding shares on the cut-off date of Wednesday, August 19, 2026, are eligible to vote. Remote e-voting will commence on Sunday, August 23, 2026, at 9:00 a.m. IST and conclude on Tuesday, August 25, 2026, at 5:00 p.m. IST. The notice of the AGM and the Annual Report have been dispatched to members whose email addresses are registered.
What to do with a filing like this
Jubilant Pharmova Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Jubilant Pharmova Limited. Read the original for the full detail.